Achieve commercial success: the value of a sound manufacturing strategy

Cell & Gene Therapy Insights 2022; 8(7), 755-771


Published: 12 August 2022
Conference Insight

May 3, 2022

Co-located with
ISCT 2022 San Francisco 

After two long-awaited years, this May, ISCT held its fourth Commercialization Signature Series forum in-person co-located at ISCT 2022 San Francisco. The forum provided the opportunity for key opinion leaders in cell and gene therapy to discuss the current state of the art in manufacturing strategy.